The Global Lichen Nitidus Treatment Market is segmented on the basis of types, which includes oral and topical treatment. On the basis of treatment, the market is segmented into corticosteroids, retinoid, antihistamines, phototherapy and other treatment. On the basis of end user, the market is segmented into hospitals, dermatology clinics, and others.
The Global Lichen Nitidus Treatment Market is expected to grow at a CAGR of 8.7% during the forecast period and is estimated to reach USD 170 million by 2023. The Lichen Nitidus Treatment Market report provides details information and strategies of the top key players in the industry.
The report also gives a broad study of the different market segments and regions.
Lichen nitidus is a rare, chronic skin disease characterized by flat-topped, and skin-colored micropapules.
Characteristics of these micropapules are the size, shape (pin point), color, location and itching. It mostly affects geriatric and pediatric population.
They commonly occur on the chest, abdomen, arms and genital areas, including the penis. In this disease, T lymphocytes get activated resulting in the formation of these micropapules.
In lichen nitidus, linear arrangement of micropapules can be seen on the fore arm or affected area.
Increasing prevalence of skin diseases across the globe is the major factor contributing the growth of the market. Unawareness about rare skin diseases among people may act as a restrain for the market growth.
Regional Analysis of the Global Lichen Nitidus Treatment Market:
The Americas accounts for the largest share of the global lichen nitidus treatment market due to increasing prevalence of skin disease, availability of treatment methods at affordable cost and demand for new topical products for its treatment. According to the American Osteopathic College of Dermatology, the number of people suffering from lichen nitidus is increasing at a steady rate in American countries.
It also stated that in 2013, USD 75 billion were spent on the treatment of various skin diseases. Aging population is another factor responsible for the market growth in these countries.
Europe is the second largest market that holds a noticeable share of the global lichen nitidus treatment market owing to an increase in the awareness regarding skin diseases, demand for skin care cosmetics, and growing market for dermatology in many European countries.
In Asia Pacific, the market is driven by increasing in number of dermatology clinics, rising demand for evidence based skin care and increasing prevalence of diseases associated with lichen nitidus such as atopic dermatitis and tuberculosis.
The Middle East & Africa is expected to show a steady but positive growth in this market due constant demand for diagnostics services in dermatology, rising awareness about lichen nitidus among children and its prevention.
Some of the key players in this market are Pfizer Inc. (U.S), Novartis AG (Switzerland), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
(U.S), Sanofi (France), GlaxoSmithKline plc. (U.K), AstraZeneca (U.K), Hubei Gedian Humanwell Pharmaceutical Co.,Ltd (China), Farmabios SPA (Italy), Horizon Pharma plc.
Report: www.marketresearchfuture.com/check/4249 .
Major TOC for Lichen Nitidus Treatment Market:
Market factor analysis
Global Lichen Nitidus Treatment market, by type
Global Lichen Nitidus Treatment Market, By Type of Content
Global Lichen Nitidus Treatment market, by technology
Global Lichen Nitidus Treatment market, by end user
Global Lichen Nitidus Treatment market, by region
Category: Market Research Publishers and RetailersCompany profile: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
For more information: